DailyDoctor Archive Specialties Get app
Back to the 19 October 2026 edition

Research · 02 of 05

Dexmedetomidine sedation linked to greater recalled ICU awareness, not better experience

Dexmedetomidine was associated with greater recalled awareness but no better overall ICU experience than propofol; individualise sedation.

Design
Planned secondary analysis of a randomised controlled trial
Population
289 ICU survivors who completed the ICE-Q at 90 days
Primary outcome
Patient-recalled ICU experience (four ICE-Q domains)
Effect
Awareness: dexmedetomidine vs propofol +3.6 (1.0-6.2); no other domain differed

A planned secondary analysis of the A2B trial (Anaesthesia, 6 October 2026) used the Intensive Care Experience Questionnaire at 90 days in 289 survivors, out of 1,009 alive, who had been randomised to dexmedetomidine, clonidine or propofol sedation.

Compared with propofol, dexmedetomidine was associated with higher awareness of surroundings (adjusted mean difference 3.6, 95% CI 1.0-6.2). Clonidine showed no clear association (2.4, -0.2 to 5.0). There were no differences in frightening memories, recall or satisfaction, and ventilation time, agitation and delirium explained little of the awareness effect.

The primary A2B trial did not show faster liberation from ventilation with the alpha-2 agonists. Together, the authors conclude these data do not support choosing dexmedetomidine over propofol for patient experience, and sedation should remain individualised.

  • Keep sedative choice individualised; this does not favour dexmedetomidine over propofol
  • Aim for light sedation and regular assessment whichever agent is used
  • Ask survivors about their ICU memories at follow-up clinic

Why it matters

It closes off patient experience as a reason to switch sedative, at least on current evidence.

Don't overread it

A secondary analysis with low questionnaire return - not evidence for changing sedation practice.

The statistics, in plain English

Only 29% of survivors returned questionnaires, so those who answered may differ from those who did not. The awareness difference has an interval excluding zero, but other domains showed nothing and this is a hypothesis-generating subgroup.

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

QR code to install Daily Doctor
Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.

acutepainchronicpainicusedationperioperativeanaesmonitoringpaedanaesairwaymgmt

Tomorrow morning, before your first patient

One edition a day for anaesthesiology, written by the desk, every claim tied to its paper. Six minutes.

Get the app — free
Daily Doctor All 27 specialties, every morning. Free.
Get the app